tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matt Miksic, 342 are a BUY (76.85%), 74 are a HOLD (16.63%), 29 are a SELL (6.52%).
Analyst Matt Miksic, currently employed at BARCLAYS, carries an average stock price target met ratio of 48.69% that have a potential upside of 18.22% achieved within 263 days.
Matt Miksic’s has documented 891 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 28-May-2026.
Analyst best performing recommendations are on ORGO (ORGANOGENESIS HOLDINGS).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 10/17/2022. The price target of $235 was fulfilled within 8 days with a profit of $44.88 (23.61%) receiving and performance score of 29.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Jun-2019
$112
$8.94 (8.67%)
$136
13 days ago
(17-Jul-2026)
15/21 (71.43%)
$11.32 (11.24%)
415
Buy Since 19-Sep-2024
$118
$14.94 (14.50%)
$115
13 days ago
(17-Jul-2026)
2/8 (25%)
$17.32 (17.20%)
143
Buy Since 18-Jul-2018
$120
$16.94 (16.44%)
$112
13 days ago
(17-Jul-2026)
10/20 (50%)
$19.32 (19.19%)
290
Buy Since 23-Oct-2018
$120
$16.94 (16.44%)
$135
13 days ago
(17-Jul-2026)
8/9 (88.89%)
$19.32 (19.19%)
339
Buy Since 02-Jun-2021
$134
$30.94 (30.02%)
$131
13 days ago
(17-Jul-2026)
9/22 (40.91%)
$33.32 (33.09%)
559
Which stock is Matt Miksic is most bullish on?
Which stock is Matt Miksic is most reserved on?
What Year was the first public recommendation made by Matt Miksic?
